Jeremy M. Levin

 
Education
 

Dr. Jeremy M. Levin is a highly accomplished individual with a significant footprint in the biotechnology and pharmaceutical industries. His educational journey began at the University of Oxford, where he earned a Bachelor of Arts (BA) in Zoology. He further advanced his education at Oxford by obtaining both a Master of Arts (MA) and a Doctor of Philosophy (DPhil) in Biochemistry, Molecular Biology, and Thermodynamics. Adding to his academic credentials, Dr. Levin also completed medical studies at the University of Cambridge, earning a Bachelor of Medicine and Bachelor of Surgery (MB BChir).

 
Professional Journey
 

Dr. Levin's career path encapsulates a blend of strategic leadership and hands-on experience across various high-profile roles.

• He commenced his professional journey with Novartis as the Global Head of Business Development and Strategic Alliances, spanning from January 2002 to July 2007. His tenure saw him contribute to the company’s growth in Cambridge, MA, and Basel, Switzerland.
• Subsequently, Dr. Levin joined Bristol-Myers Squibb, serving as the Senior Vice President for Strategy, Alliances, and Transactions from August 2007 to January 2012.
• His strategic acumen led him next to Teva Pharmaceutical Industries Ltd., where he held the positions of President and CEO from February 2012 to November 2013.
• Following a brief sabbatical as a thinker and advisor, Dr. Levin returned to the professional sphere with significant roles, including his current position as Chairman and CEO of Ovid Therapeutics Inc., based in Manhattan, New York, which he has held since April 2015.

 
Board Memberships
 

Dr. Levin's career isn't confined to executive roles alone. He has been an influential figure on various boards globally.

• He has been a board member of the Biotechnology Innovation Organization (BIO) since June 2016, even holding the position of Chairman from June 2019 to June 2022 before becoming Chairman Emeritus.
• He also serves as Chairman of the Board for Opthea since January 2021, and as a board member for Lundbeck in Denmark since March 2017.
• Additionally, he was part of the board of Biocon Ltd in India from January 2015 to January 2020.

 
Career Achievements
 

His career achievements reflect his strong leadership skills, strategic development, and implementation capabilities. He has been instrumental in driving the growth and success of several companies by focusing on product pipeline development, international market expansion, and forming strategic alliances. Dr. Levin's academic background and varied professional experiences have made him a respected and influential leader in his field.